Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 7 of 7 for “"Benserazide"”.
-
Neurophysiological Traces of L-Dopa Induced Dyskinesia in the Bed Nucleus Of The Stris Terminalis of 6-OHDA Lesioned Rats
… of saline, or l-dopa (6mg/kg, i.p.) in benserazide (15mg/kg, i.p.), or benserazide alone. Benserazide is a peripheral inhibitor of DOPA-decarboxylase used to increase the central availability of dopamine (DA) and is generally administered with l-dopa, and thus was used as our vehicle …
-
Structure-Activity Relationship Studies of Mitochondrial Uncouplers and PilB Inhibitors
… the structure-activity relationship of benserazide in the pursuit of treating drug-resistant bacterial diseases. Antimicrobial resistance is an imminent health threat worldwide due to the increasing resistances to common antibiotics of many lethal pathogens. Overuse and underdevelopment …
-
The Type IV Pilus Assembly ATPase PilB as a Regulator of Biofilm Formation and an Antivirulence Target
… chemical library led to the identification of benserazide and levodopa as CtPilB inhibitors. We show that both compounds inhibit T4P assembly in M. xanthus without any detrimental effects on bacterial growth. Furthermore we demonstrate that both levodopa and benserazide inhibit T4P-mediated …
-
The effects of age and L-DOPA replacement on locomotor deficits in the AS/AGU mutant rat
… with L-DOPA administration (25 mg/kg/day ip + benserazide 2.5mg/kg/day ip) for 4 weeks. This drug is the standard treatment for human Parkinson's Disease. L-DOPA ameliorated mid-air righting, and performance on certain inclined ramps in AS/AGU rats. Most striking was the improvement in …
-
Therapeutic strategies of Parkinson's disease: Alternative dopamine replacement and potential drug targets
… via oral tablet dosing of L-DOPA/carbidopa or benserazide 3-4 times/day remains the most effective and well-tolerated treatment, one that significantly improves the motor symptoms and quality of life of patients in the early stages of PD. However, due to L-DOPA's non-continuous, pulsatile …
-
Synthesis and evaluation of nitrocatechol derivatives of chalcone as inhibitors of monoamine oxidase and catechol-O-methyltransferase
… barrier. AADC inhibitors (carbidopa and benserazide), and COMT inhibitors (tolcapone and entacapone) will block the peripheral action of AADC and COMT, thereby reducing the conversion of levodopa to dopamine. A larger fraction of levodopa is thus available to cross the blood-brain …
-
Anatomical and Physiological Characterization of Striatal Activation of the Cerebral Cortex
… compared with WT mice. 10mg/kg L-dopa and 3mg/kg benserazide systemic administration significantly increased the c-Fos expression in the striatum, the entire cerebral cortex including the motor cortex, and the key brain areas in striatal-thalamocortical circuit (motor thalamus, GPe, STN, and SNr) …